Skip to main content
. 2012 Oct 16;9(1):27–33. doi: 10.1200/JOP.2012.000627

Table 2.

Study Population Demographic and Clinical Characteristics

Characteristic Total
No. of Medical Oncologists in HSA
P
None
One to Two
Three to Eight
≥ Nine
No. % No. % No. % No. % No. %
Total 9,262 100.0 651 7.03 884 9.54 1,655 17.87 6,072 65.56
Age at diagnosis, years .37
    67-70 1,803 19.47 125 19.2 186 21.04 334 20.18 1,158 19.07
    71-75 2,178 23.52 151 23.2 209 23.64 395 23.87 1,423 23.44
    76-80 2,234 24.12 171 26.27 217 24.55 356 21.51 1,490 24.54
    81-85 1,846 19.93 120 18.43 163 18.44 357 21.57 1,206 19.86
    ≥ 86 1,201 12.97 84 12.9 109 12.33 213 12.87 795 13.09
Race/ethnicity < .001
    White 7,602 82.08 564 86.64 752 85.07 1,431 86.47 4,855 79.96
    Black 735 7.94 46 7.07 50 5.66 82 4.95 557 9.17
    Hispanic 417 4.5 23 3.53 56 6.33 67 4.05 271 4.46
    Other 508 5.48 18 2.76 26 2.94 75 4.53 389 6.41
Sex .13
    Male 3,870 41.78 276 42.4 398 45.02 666 40.24 2,530 41.67
    Female 5,392 58.22 375 57.6 486 54.98 989 59.76 3,542 58.33
Marital status < .001
    Married 4,631 50.0 329 50.54 457 51.7 816 49.31 3,029 49.88
    Not married 4,258 45.97 289 44.39 372 42.08 764 46.16 2,833 46.66
    Unknown 373 4.03 33 5.07 55 6.22 75 4.53 210 3.46
Medicaid status .08
    No Medicaid 7,617 82.24 531 81.57 721 81.56 1,365 82.48 5,000 82.35
    Medicaid before and after diagnosis 1,420 15.33 101 15.51 139 15.72 242 14.62 938 15.45
    Medicaid before or after diagnosis* 225 2.43 19 2.92 24 2.71 48 2.9 134 2.21
Comorbidity score .28
    0 4,332 46.77 307 47.16 421 47.62 729 44.05 2,875 47.35
    1 2,777 29.98 196 30.11 262 29.64 506 30.57 1,813 29.86
    ≥ 2 2,153 23.25 148 22.73 201 22.74 420 25.38 1,384 22.79
Income < .001
    ≤ $20,000 317 3.42 34 5.22 43 4.86 49 2.96 191 3.15
    $20,001-$25,000 494 5.33 40 6.14 73 8.26 90 5.44 291 4.79
    $25,001-$30,000 779 8.41 134 20.58 86 9.73 153 9.24 406 6.69
    ≥ $30,001 7,672 82.83 443 68.05 682 77.15 1,363 82.36 5,184 85.38
Initiated chemotherapy within 3 months after colectomy .008
    No 3,640 39.3 291 44.7 328 37.1 623 37.64 2,398 39.49
    Yes 5,622 60.7 360 55.3 556 62.9 1,032 62.36 3,674 60.51
Diagnosis year .41
    2000 1,502 16.22 101 15.51 134 15.16 251 15.17 1,016 16.73
    2001 1,552 16.76 108 16.59 137 15.5 306 18.49 1,001 16.49
    2002 1,609 17.37 119 18.28 143 16.18 293 17.7 1,054 17.36
    2003 1,629 17.59 118 18.13 161 18.21 263 15.89 1,087 17.9
    2004 1,478 15.96 100 15.36 147 16.63 268 16.19 963 15.86
    2005 1,492 16.11 105 16.13 162 18.33 274 16.56 951 15.66
Survival time, months .52
    6-12 999 9.78 64 9.83 86 9.72 191 11.54 658 10.84
    13-24 1,484 16.02 116 17.82 159 17.99 268 16.19 941 15.5
    25-36 1,966 21.23 148 22.73 200 22.62 364 21.99 1,254 20.65
    37-48 1,427 15.41 96 14.75 136 15.38 250 15.11 945 15.56
    49-60 1,211 13.07 77 11.83 113 12.78 208 12.57 813 13.39
    ≥ 60 2,175 23.48 150 23.04 190 21.49 374 22.6 1,461 24.06
Region < .001
    West 3,648 39.39 180 27.65 342 38.69 595 35.95 2,531 41.68
    Northeast 2,336 25.22 84 12.9 202 22.85 521 31.48 1,529 25.18
    Midwest 1,521 16.42 141 21.66 148 16.74 201 12.15 1,031 16.98
    South 1,757 18.97 246 37.79 192 21.72 338 20.42 981 16.16
Registry at diagnosis < .001
    San Francisco 352 3.8 23 2.6 116 7.01 > 210 > 3.45
    Connecticut 654 7.06 17 2.61 32 3.62 119 7.19 486 8.0
    Detroit 748 8.08 29 3.28 > 80 > 4.83 634 10.44
    Hawaii 141 1.52 30 1.81 91 1.5
    Iowa 773 8.35 140 21.51 119 13.46 117 7.07 397 6.54
    New Mexico 227 2.45 29 4.45 51 5.77 32 1.93 115 1.89
    Seattle 444 4.79 28 4.3 > 15 > 1.7 395 6.51
    Utah 231 2.49 25 3.84 28 3.17 30 1.81 148 2.44
    Atlanta and rural Georgia 251 2.71 15 2.31 18 2.03 19 1.15 > 195 > 3.21
    San Jose 174 1.88 15 1.7 158 2.6
    Los Angeles 664 7.17 28 3.17 > 35 > 2.11 590 9.72
    Greater California 1,415 15.28 79 12.14 169 19.12 346 20.91 821 13.52
    Kentucky 803 8.67 113 17.36 87 9.84 241 14.56 362 5.96
    Louisiana 703 7.59 118 18.13 87 9.84 78 4.71 420 6.92
    New Jersey 1,682 18.16 67 10.29 170 19.23 402 24.29 1,043 17.18
*

Medicaid eligible before diagnosis and Medicaid eligible after diagnosis were combined for confidentiality reasons but were analyzed as separate groups.

Survival times of 6 months and 7-12 months were combined for confidentiality reasons but were analyzed as separate groups.

To protect confidentiality, small cell sizes are suppressed.